Clinical Trial: Characterization of the Melanoma-Specific Immune Response

Clinical Trial: Characterization of the Melanoma-Specific Immune Response

Sponsor and Collaborators

University of California, Davis

Contact

Contact: Jennifer Nava
916-734-1438
jennifer.nava@ucdmc.ucdavis.edu

Contact: Sepideh Bagheri, M.D.
916-734-6547
sepideh.bagheri@ucdmc.ucdavis.edu

Principal Investigator
Emanual Maverakis, M.D. University of California, Davis

ClinicalTrials.gov Identifier
NCT00368615
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs